Overview

Clinical Study of NK Cells in the Treatment of Severe Endometriosis

Status:
Not yet recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
Dysfunction of natural koller cells (NK cells) is an important factor in the development of endometriosis. NK cell therapy was applied to treat severe endometriosis, which is an exploration of the pathogenesis of this refractory disease.
Phase:
Phase 1
Details
Lead Sponsor:
Shenzhen People's Hospital